Impact of immunosuppression on mortality in critically ill COVID-19 patients
- PMID: 33103761
- DOI: 10.1111/bjh.17108
Impact of immunosuppression on mortality in critically ill COVID-19 patients
Comment in
-
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.Br J Haematol. 2020 Nov;191(3):505-506. doi: 10.1111/bjh.17110. Epub 2020 Oct 26. Br J Haematol. 2020. PMID: 33103782 No abstract available.
Comment on
-
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy.Br J Haematol. 2020 Oct;191(2):194-206. doi: 10.1111/bjh.17027. Epub 2020 Aug 12. Br J Haematol. 2020. PMID: 32678948 Free PMC article.
References
-
- Fox TA, Troy-Barnes E, Kirkwood AA, Chan WY, Day J, Chavda SJ, et al. Clinical outcomes and risk factors for severe COVID-19 infection in patients with haematological disorders receiving chemo- or immunotherapy. Br J Haematol. 2020. https://doi.org/10.1111/bjh.17027.
-
- Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, et al. Immunology of COVID-19: Current State of the Science. Immunity. 2020;52(6):910-41.
-
- Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-10.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
